Anzeige
Mehr »
Login
Dienstag, 17.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Der Markt erwartet spektakuläre News, welche diese Aktie sofort explodieren lassen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
456 Leser
Artikel bewerten:
(2)

Honda Foundation: Honda Prize 2021 Awarded to French Neurosurgeon and Physicist Dr. Alim Louis Benabid

Finanznachrichten News

- Pioneering Research into Deep Brain Stimulation (DBS) (*) and Contribution to Treating Involuntary Movement Caused by Parkinson's Disease -

TOKYO, Sept. 30, 2021 /PRNewswire/ -- The Honda Foundation, the public interest incorporated foundation established by Soichiro Honda and his younger brother Benjiro and currently led by President Hiroto Ishida, is pleased to announce that the Honda Prize 2021 will be awarded to Dr. Alim Louis Benabid, Professor Emeritus of Joseph Fourier University and Chairman of the Board of Clinatec, both of France, for his contribution to pioneering research and practical application of deep brain stimulation (DBS) to the treatment of involuntary movement caused by progressive Parkinson's disease and other neurological disorders.

(Logo: https://kyodonewsprwire.jp/img/202109210324-O3-UtH2e7LX)

(Photo: https://kyodonewsprwire.jp/img/202109210324-O2-qCGj2TiR)

The Honda Prize, established in 1980 and awarded once each year, is an international award that recognizes the work of individuals or groups generating new knowledge to drive the next generation, from the standpoint of ecotechnology. Dr. Benabid was the first to make use of DBS for the treatment of involuntary movement, caused mainly by progressive Parkinson's disease, and to succeed in its practical application. DBS is a surgical procedure in which electrodes are implanted in the subthalamic nucleus in the brain. Stimulation by high-frequency electric current from electrodes reduces tremors and restores the motor function of Parkinson's disease patients. Recognition of its effectiveness in clinical studies led to the dissemination of DBS worldwide, with more than 150,000 patients undergoing this procedure to date.

If involuntary tremors cannot be controlled with drug therapy considered best suited to treat Parkinson's disease, a surgical procedure known as thalamotomy was commonly performed to destroy a tiny portion of the brain. On the other hand, DBS is a reversible procedure in which the implanted electrodes can not only be removed but also adjusted to fine-tune the strength of the current. DBS can be used to treat not only Parkinson's but also dystonia and other motor disorders, and contributes to improving the quality of life of many, including restoring the ability to stand alone, for example. The Prize will be awarded to Dr. Benabid for this innovative treatment method, which is worthy of the highest recognition.

This year, the presentation ceremony for the 42nd Honda Prize will be held on November 17, 2021, in an online format, to be broadcast in Japan, France and various other countries.

(*) DBS: Electrodes are implanted around the subthalamic nucleus of the brain, along with a stimulation generator placed in the chest. The two are connected with a lead for high-frequency electrical stimulation. This aids in restoring movement functions, and curbing tremors and other symptoms for improved mobility in everyday living.

For more information about the press release and CV of Dr. Benabid, please refer to the Honda Foundation via: URL: https://www.hondafoundation.jp/news/view_en/1504

Official website: https://www.hondafoundation.jp/en

© 2021 PR Newswire
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.